Prince Pharmaceutical Co., Ltd. (TPEX:6935)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.00
0.00 (0.00%)
Apr 29, 2026, 1:45 PM CST

Prince Pharmaceutical Revenue

In the year 2025, Prince Pharmaceutical had annual revenue of 1.06B TWD with 53.07% growth. Prince Pharmaceutical had revenue of 608.14M in the half year ending December 31, 2025, with 53.06% growth.

Revenue
1.06B
Revenue Growth
+53.07%
P/S Ratio
1.01
Revenue / Employee
4.89M
Employees
216
Market Cap
1.06B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.06B366.18M53.07%
Dec 31, 2024690.03M-63.30M-8.40%
Dec 31, 2023753.33M40.80M5.73%
Dec 31, 2022712.53M271.45M61.54%
Dec 31, 2021441.08M145.28M49.12%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Anxo Pharmaceutical 883.22M
Original BioMedicals 381.00K
Mediera 229.85M
Excelsior Biopharma 898.26M
DV Biomed 794.18M
Winston Medical Supply 700.07M
GeneFerm Biotechnology 677.10M
InnoPharmax 68.99M
Revenue Rankings